Holland-Frei Cancer Medicine, 10th Edition

~~€371.00~~ €333.90(-10%)

HOLLAND-FREI CANCER MEDICINEThe latest edition of the gold-standard in cancer science and clinical oncology references

In the newly revised Tenth Edition of Holland-Frei Cancer Medicine, a team of distinguished researchers and practitioners delivers a comprehensive and up-to-date discussion of cancer science and clinical oncology practice. The book contains timely and indispensable information on epidemiology, etiology, cancer biology, immunology, prevention, screening, clinical presentation, pathology, imaging, and therapy.

Grounded in a fundamental understanding of cancer biology, Holland-Frei Cancer Medicine combines scientific principles with clinical practice. It contains hundreds of full-color illustrations and photographs, tables, graphs, and algorithms that complement and enhance the complex topics discussed within the book. This book is an invaluable clinical tool that provides readers with overview boxes, additional references, and other pedagogic features designed to make the content easy to access and comprehend.

Readers will also find:

A translational and integrated approach throughout the book that combines cancer biology with cancer management
A strong emphasis on multidisciplinary, research-driven patient care that improves outcomes and allows for the optimal use of all clinically appropriate therapies
Discussions of the most current personalized cancer care, including molecular diagnostics and therapeutics

Perfect for medical oncologists, radiation oncologists, and internists, Holland-Frei Cancer Medicine, Tenth Edition will also earn a place in the libraries of allied health professionals involved in the treatment of cancer patients.

This book is published in collaboration with the American Association for Cancer Research: https://www.aacr.org/

ABOUT THE AUTHOR

Edited by

Robert C. Bast Jr., MD, Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

John C. Byrd, MD, The Gordon and Helen Hughes Taylor Professor and Chair, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Carlo Croce, MD, Distinguished University Professor, The Ohio State University, The John W. Wolfe Chair in Human Cancer Genetics, Professor and Chair, Department of Cancer Biology and Genetics The Wexner Medical Center, The Ohio State University, Columbus, OH, USA

Ernest Hawk, MD, MPH, Vice President for Cancer Prevention & Head, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Fadlo R. Khuri, MD, President and Professor of Internal Medicine, Hematology and Medical Oncology, The American University of Beirut, Beirut, Lebanon

Raphael Pollock, MD, PhD, FACS, Director, The Ohio State University Comprehensive Cancer Center, Kathleen Wellenreiter Klotz Chair in Cancer Research, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Apostolia M. Tsimberidou, MD, PhD, Professor, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Christopher Willett, MD, Professor and Chair, Department of Radiation Oncology, Duke University School of Medicine, Boston, Massachusetts, USA

Cheryl Willman, MD, Executive Director, Mayo Clinic Cancer Center Programs: Mayo Rochester/Midwest, Mayo Arizona, Mayo Florida, London, Abu Dhabi, Director, Mayo Clinic Comprehensive Cancer Center, Professor of Laboratory Medicine and Pathology, College of Medicine, Mayo Clinic Cancer Center, Rochester, NY, USA